ALLMedicine™ Mononucleosis Center

Mar 11th, 2023 - Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal systemic inflammation disease in children. The most common cause is Epstein-Barr virus (EBV) infection. MHC class I polypeptide-related sequence B (MICB) is a membrane protein inducib...

Mar 10th, 2023 - Study Description: This is a multisite randomized, double-blinded phase 1/2 study to evaluate the immunogenicity and safety of a 2-dose regimen of an adjuvanted Epstein-Barr virus (EBV) glycoprotein (gp) 350-Ferritin nanoparticle vaccine in EBV-se...

Mar 2nd, 2023 - Practice Essentials Lymphoproliferative disorders (LPDs) in children represent a heterogeneous group of conditions characterized by the expansion of monoclonal or polyclonal lymphoid cells in the setting of immune dysfunction. The risk of true mal...

Mar 2nd, 2023 - Practice Essentials Lymphoproliferative disorders (LPDs) in children represent a heterogeneous group of conditions characterized by the expansion of monoclonal or polyclonal lymphoid cells in the setting of immune dysfunction. The risk of true mal...

Mar 2nd, 2023 - Practice Essentials Lymphoproliferative disorders (LPDs) in children represent a heterogeneous group of conditions characterized by the expansion of monoclonal or polyclonal lymphoid cells in the setting of immune dysfunction. The risk of true mal...

Mar 10th, 2023 - Study Description: This is a multisite randomized, double-blinded phase 1/2 study to evaluate the immunogenicity and safety of a 2-dose regimen of an adjuvanted Epstein-Barr virus (EBV) glycoprotein (gp) 350-Ferritin nanoparticle vaccine in EBV-se...

Feb 9th, 2023 - Epstein-Barr virus (EBV) belongs to herpesviridae family, which infects more than 90% of the population. EBV infection is usually asymptomatic and establishes lifelong persistence in the host, although primary infection later than adolescence freq...

Feb 6th, 2023 - Epstein-Barr virus (Epstein-Barr virus), also known as human herpesvirus type 4, has an infection rate of over 90% in the population. The global disease burden caused by EBV infection is enormous, and it was one of the first human cancer viruses t...

Dec 23rd, 2022 - Worldwide, 95% of adults are infected with Epstein-Barr Virus (EBV). These infections may cause different diseases. In most cases, EBV infection is asymptomatic because of a highly effective host immune response. Some individuals develop infectiou...

Dec 13th, 2022 - EBV is one of several herpesviruses that cause disease in humans. Primary EBV infection usually occurs in early childhood and is generally asymptomatic, while later infection may cause mononucleosis. As with other herpesviruses, primary infection ...

Feb 28th, 2023 - SAN DIEGO – Epstein-Barr Virus (EBV) infection is widely recognized as a contributor to risk of multiple sclerosis (MS). Although most adults have been exposed, it is very rare to find MS in an individual with no prior EBV exposure.

Aug 12th, 2022 - A substantial proportion of gastric cancers worldwide was linked with the Epstein-Barr virus (EBV), according to a meta-analysis. In a pooled analysis involving over 68,000 patients with conventional gastric adenocarcinoma in 37 countries, EBV pre...

Apr 14th, 2022 - Dr. Obeidat is an Assistant Professor in the Department of Neurology, Neuroimmunology and Multiple Sclerosis and is the Founding Director of the Neuroimmunology and MS Fellowship Program at The Medical College of Wisconsin in Milwaukee, WI.

Apr 13th, 2022 - Tian Zhang, MD:I’d love to think a little more about not just subsets of patients but also the role for biomarkers. Dr Braun, is there a role for biomarkers in 2022, in terms of thinking about our patients and treatment decision-making? In particu...

Mar 17th, 2022 - This transcript has been edited for clarity. Hello. I'm Paul Auwaerter with Medscape Infectious Diseases, speaking from the Johns Hopkins University School of Medicine. There have been two recent papers that have brought Epstein-Barr virus, otherw...